. 2016 Dec 22;6:39787. doi: 10.1038/srep39787

Table 2. Comparison of GPS-PAIL with ASEB¹¹,³², by using 158 non-human HAT-specific sites of 45 proteins as the testing data set.

	HAT	Positive^a	Negative	Pr	Sn	Sp
GPS-PAIL (LOO)	CREBBP	167	1719	16.12	38.32	80.63
	EP300	411	3525	22.81	50.61	80.03
	HAT1	10	110	62.50	100.00	94.55
	KAT2A	32	265	30.56	68.75	81.13
	KAT2B	69	954	17.17	49.28	82.81
	KAT5	28	531	39.29	39.29	96.80
	KAT8	6	177	33.33	83.33	94.35
GPS-PAIL (Testing)	CREBBP	81	405	28.32	39.51	80.00
	EP300	85	605	25.85	44.71	81.98
	HAT1	5	33	100.00	100.00	100.00
	KAT2A	37	430	19.23	54.05	80.47
	KAT2B	40	133	47.92	57.50	81.20
	KAT5	4	7	100.00	100.00	100.00
	KAT8	4	139	36.36	100.00	94.96
ASEB (Testing)	CREBBP/EP300	107	771	22.61	42.06	80.03
ASEB (Testing)	KAT2A/KAT2B	73	522	23.08	41.10	80.84

For convenience, the LOO results of GPS-PAIL on our training data set were also provided. a. Positive, the number of positive sites.

Table 2. Comparison of GPS-PAIL with ASEB11,32, by using 158 non-human HAT-specific sites of 45 proteins as the testing data set.